[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@PracticalNeuro Practical Neurology
Practical Neurology posts on X about $abbv, people with, medtronic, X months the most. They currently have XXXXXX followers and XX posts still getting attention that total XX engagements in the last XX hours.
Engagements: XX #
- X Week XXXXX +39%
- X Month XXXXXX +1,194%
- X Months XXXXXX +24%
- X Year XXXXXX +91%
Mentions: X #
Followers: XXXXXX #
- X Week XXXXXX +0.21%
- X Month XXXXXX +0.92%
- X Months XXXXXX +4.10%
- X Year XXXXXX +7%
CreatorRank: undefined #
Social Influence #
Social category influence stocks
Social topic influence $abbv #63, people with #461, medtronic, 6 months, longterm
Top assets mentioned AbbVie Inc (ABBV) Medtronic PLC (MDT)
Top Social Posts #
Top posts by engagements in the last XX hours
"The @US_FDA has approved #Altaviva (@Medtronic) an implantable #neuromodulation device designed to treat urge urinary incontinence a symptom that can be associated with conditions like #Parkinsons #Multiple_Sclerosis #Stroke and more. @AANmember @ACPIMPhysicians"
X Link @PracticalNeuro 2025-09-24T20:01Z 18K followers, XXX engagements
"#Botox treatment improved functional outcomes in people with upper limb essential #tremor vs placebo according to study results presented at #MDS2025. @movedisorder @MichaelJFoxOrg @essentialtremor @AbbVie"
X Link @PracticalNeuro 2025-10-12T14:01Z 18K followers, 1881 engagements
"People with advanced idiopathic #Parkinson disease treated with #Foslevodopa/#Foscarbidopa showed improvements in motor and non-motor symptoms at X months in a study presented at #MDS2025. #Vyalev @AbbVie @Movedisorder @MichaelJFoxOrg"
X Link @PracticalNeuro 2025-10-13T12:01Z 18K followers, XXX engagements
"Treatment with #Ultomiris (#ravulizumab) for those with #NMOSD was associated with long-term relapse prevention in data presented at #ECTRIMS2025. @ECTRIMS @AlexionPharma @AstraZeneca @mssociety"
X Link @PracticalNeuro 2025-10-04T20:00Z 18K followers, 1149 engagements
"Results from phase X #NIMBLE trial: @Regeneron announces #cemdisiran monotherapy significantly improved MG-ADL and QMG scores in adults with generalized #Myasthenia_Gravis vs placebo. @MyastheniaOrg @AANEMorg @mssociety"
X Link @PracticalNeuro 2025-09-04T22:00Z 18K followers, XXX engagements